NCT06304233Active, not recruiting
The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease
The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease - The Link Between DISC1 and Cardiac Function in Patients With Schizophrenia
Source: ClinicalTrials.gov · Last updated 8 Jul 2026
Brief summary (registry, in English)
To study the association between DISC1 RNA expression levels and cardiac function in patients with schizophrenia.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 11 Dec 2023
- Start date
- 13 Dec 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Norwegian University of Science and Technology
- Diseases
- Schizophrenia
- NCT number
- NCT06304233
What you commit to
- Study type: Observational
- Planned participants: 120
- From 13 Dec 2023 to the primary completion date, 31 Dec 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current or previous diagnosis of cancer
- Current or previous treatment with chemotherapy
Other
- Current pregnancy
- Mothers less than 6 months post-partum
Who the study is looking for
- Patients with ICD-10 schizophrenia, schizotypal or delusional disorders (F20 to F29)
- Both inpatient and outpatient
- Capable of giving informed consent
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| St. Olavs Hospital, Trondheim University Hospital Coordinator of this site? Confirm its status | Trondheim | Norway | Unknown status |
| Norwegian University of Science and Technology Coordinator of this site? Confirm its status | Trondheim | Norway | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.